Generic selectors
Exact matches only
Search in title
Search in content
Filter by Categories

Intervenn attracts $201m in series C

Intervenn Biosciences was co-founded by faculty members at Stanford University and University of California, Berkeley.

Planted grows with $21m

New and returning investors have chipped into the ETH Zurich plant-based meat spinout’s pre-series B round, five months after it completed a series A.

T-Knife secures $110m in series B

The MDC spinout raised a series B round which will be used to boost its manufacturing capacity and advance its pipeline of candidates.


GCV Digital Forum - July 2021
21st July 2021
GCVI Summit 2021
29th September 2021
GCV Symposium 2021
3rd November 2021
Everactive tops up series C
The industrial sensor manufacturer spun out of Michigan and Virginia has increased its latest round to $51m in a tranche backed by 3M, Ericsson and Armstrong International.
Michigan pre-seed fund adds $6.5m
The MSU Foundation-run Pre-Seed III Fund has secured an additional $6.5m from MEDC, more than a year after the vehicle was formed with $3m.
Icosavax lands on $182m IPO
UW's vaccine development company has listed on Nasdaq, with its shares rising on the first day of trading.
Tenaya tends to $180m IPO
The GV-backed cardiovascular therapeutics company has priced an upsized offering on Nasdaq, with the shares closing just marginally higher on the first day.
Daily deal net: July 30, 2021
Every day, Global University Venturing rounds up the smaller investments from across the university innovation ecosystem in its deal net.
Deep Genomics jumps into $180m series C
University of Toronto-linked Deep Genomics has picked up $180m in its series C round led by SoftBank Vision Fund 2.
test reg